Description

5,6-Dihydro-Imidazo[1,5-A]Pyrazine-3,7(8H)-Dicarboxylic Acid 7-(1,1-Dimethylethyl) Ester is a high-purity, advanced pharmaceutical intermediate crucial for modern drug discovery and development. This compound serves as a key synthetic building block for constructing complex heterocyclic scaffolds found in active pharmaceutical ingredients (APIs). It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the synthesis of novel therapeutic agents, particularly in areas requiring sophisticated nitrogen-containing heterocycles.

Application

• Pharmaceutical Intermediate: A critical building block in the multi-step synthesis of novel drug candidates, especially those targeting the central nervous system (CNS) and oncology.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities with improved efficacy and safety profiles.
• API Synthesis: Integral to the production route of complex Active Pharmaceutical Ingredients (APIs) that contain the imidazopyrazine core structure.
• Bioconjugation & Probe Development: Serves as a precursor for creating chemical probes and bioconjugates used in biochemical assays and diagnostic research.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Item	Details
Product Name	5,6-Dihydro-Imidazo[1,5-A]Pyrazine-3,7(8H)-Dicarboxylic Acid 7-(1,1-Dimethylethyl) Ester
CAS No.	1432058-58-6
Molecular Formula	C13H19N3O4
Molecular Weight	281.31 g/mol
Synonyms	tert-Butyl 3,7-dioxo-2,3,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazine-8-carboxylate; 5,6-Dihydro-8H-imidazo[1,5-a]pyrazine-3,7-dicarboxylic acid 7-(1,1-dimethylethyl) ester; 8-(tert-Butoxycarbonyl)-2,3,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazine-3,7-dione; CAS 1432058-58-6; Imidazopyrazine tert-butyl ester derivative
EINECS	Contact for details

Quality Control

Our 5,6-Dihydro-Imidazo[1,5-A]Pyrazine-3,7(8H)-Dicarboxylic Acid 7-(1,1-Dimethylethyl) Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure high purity and consistency, meeting the stringent requirements for pharmaceutical R&D. Comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with every shipment to support your regulatory and quality documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). For long-term storage, consider keeping the material under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.